Uncover key drivers, emerging technologies, and competitive movements shaping the nanotechnology in cancer treatment market from 2025–2034 with trusted insights from The Business Research Company

How Big Is The Nanotechnology In Cancer Treatment Market Today And What Is Its Future Size?

The market size for nanotechnology in cancer treatment has experienced swift expansion recently. It is projected to increase from $137.90 billion in 2024 to $159.09 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 15.4%. Historical expansion in this market is primarily due to the escalating global prevalence of cancer, heightened awareness regarding early cancer detection, a surge in research and development investments within nanomedicine, the growing embrace of minimally invasive treatments, and increased government financial support for oncology nanotech research.

The nanotechnology in the cancer treatment market size is projected to experience swift expansion over the coming years. This market is anticipated to reach $278.07 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 15.0%. The expansion during the forecast period is attributable to the increasing demand for targeted cancer treatments, the heightened incorporation of nanotechnology into drug delivery mechanisms, a greater emphasis on individualized oncology approaches, a surge in clinical trials for nano-based cancer medications, and the increasing use of nanotheranostics in cancer management. Significant trends for the forecast timeframe encompass progress in nanoparticle drug delivery platforms, novel developments in cancer-specific nanocarriers, the fusion of AI with nanotechnology for precise oncology, the creation of versatile nanodevices for diagnostic and therapeutic applications, and the broadened application of nanotheranostics within personalized medicine.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27357&type=smp

What External And Internal Drivers Are Influencing The Nanotechnology In Cancer Treatment Market?

The increasing need for targeted therapies is anticipated to drive the expansion of nanotechnology within the cancer treatment market in the future. These treatments focus on specific molecular indicators or biological routes crucial for tumor development and spread. Their growing appeal stems from their capacity to accurately target cancer cells, thereby limiting harm to healthy tissues and reducing adverse reactions. Within cancer treatment, nanotechnology boosts targeted therapies by facilitating the exact delivery of medications straight to malignant cells, enhancing efficacy and lessening damage to healthy cells. As an illustration, a report released in July 2023 by the American Society of Gene & Cell Therapy (ASGCT), a US-based professional membership organization, indicated that the count of gene therapies in Phase II was 247 at the close of Q1 2023, increasing by 5% to 260 by the end of Q2 2023. Consequently, the increasing requirement for targeted therapies is fueling the expansion of nanotechnology in the cancer treatment market.

How Is The Nanotechnology In Cancer Treatment Market Categorized Across Applications And Types?

The nanotechnology in cancer treatment market covered in this report is segmented

1) By Nanotechnology Type: Liposomes, Dendrimers, Nanoparticles

2) By Treatment Type: Chemotherapy, Immunotherapy, Targeted Therapy, Combined Therapy Approaches, Surgery Assistance

3) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Blood Cancer, Other Cancer Types

4) By Application: Targeted Drug Delivery, Photothermal Therapy, Radiation Therapy Enhancement, Diagnostics And Imaging, Gene Delivery Systems

5) By End-User: Hospitals, Research Institutions, Diagnostics Laboratories, Pharmaceutical Companies, Contract Research Organizations (CROs)

Subsegments:

1) By Liposomes: Conventional Liposomes, Stealth Liposomes, Cationic Liposomes, Immunoliposomes

2) By Dendrimers: Polyamidoamine Dendrimers, Polypropyleneimine Dendrimers, Peptide-Based Dendrimers, Carbosilane Dendrimers

3) By Nanoparticles: Gold Nanoparticles, Magnetic Nanoparticles, Polymeric Nanoparticles, Quantum Dots, Lipid Nanoparticles

How Are Market Trends Influencing Competition In The Nanotechnology In Cancer Treatment Market?

Major companies operating in the nanotechnology in cancer treatment market are concentrating on developing sophisticated treatments, such as immunotherapy nano formulation, to improve immune system targeting and reduce adverse effects in cancer patients. Immunotherapy nano formulation leverages nanotechnology to deliver immune-based therapies directly to specific target sites, thereby enhancing treatment precision while simultaneously boosting drug stability, bioavailability, and the activation of an immune response. For instance, in December 2023, Cello Therapeutics, a US-based biotechnology company, introduced CE120, a broad-spectrum therapeutic cancer nano vaccine that secured Food and Drug Administration clearance. This therapy marks the first clinical use of platelet membrane-coated nanoparticles for treating solid tumors. CE120 integrates targeted drug delivery with immune system activation, aiming to destroy tumors and prevent recurrence. Its unique nanotechnology platform enhances both therapeutic precision and immune response. This milestone establishes CE120 as a pioneering nanomedicine in cancer treatment.

Who Are The Global Leaders Steering The Nanotechnology In Cancer Treatment Market Forward?

Major companies operating in the nanotechnology in cancer treatment market are Pfizer Inc., AstraZeneca PLC, Novartis AG, Amgen Inc., GE Healthcare Technologies Inc., Eisai Co. Ltd., Jazz Pharmaceuticals plc, Arrowhead Pharmaceuticals Inc., Nanobiotix S.A., EnGeneIC Ltd., Nanospectra Biosciences Inc., Sona Nanotech Inc., CritiTech Inc., Immix Biopharma Inc., DNA Nanobots LLC, Nanovery Limited, CytImmune Sciences Inc., NanOlogy LLC, NanoApps Medical Inc., ARIZ Precision Medicine.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/nanotechnology-in-cancer-treatment-global-market-report

What Are The Emerging Regional Trends Driving The Nanotechnology In Cancer Treatment Market?

North America was the largest region in the nanotechnology in cancer treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanotechnology in cancer treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=27357&type=smp

Browse Through More Reports Similar to the Global Nanotechnology In Cancer Treatment Market 2025, By The Business Research Company

Biosurfactants Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biosurfactants-global-market-report

Biomaterials Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biomaterials-global-market-report

Biosurgery Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biosurgery-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model